InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Poradosu Enrique, Autre. Officer active across 1 companies, notably Nuvectis Pharma, Inc.. Aggregated, 4 disclosures have been logged. Total volume traded: €28k. The latest transaction was filed on 12 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
€5,261370 shares@ €14.22020.0018% mcap19.1% of flow
Common Stock
SEC:0001104659-22-060908:0·
Ideal exit: 6 Feb 2023 (T+270)
060,000 shares0
Common Stock
SEC:0001104659-22-042815:0·
€11,1323,800 shares@ €2.9294100.0% of flow
Common Stock, par value $0.00001
SEC:0001104659-22-014376·
Ideal exit: 1 Nov 2022 (T+270)
€11,1323,800 shares@ €2.92940.0038% mcap40.4% of flow
Common Stock, par value $0.00001
SEC:0001104659-22-014376:0·
Ideal exit: 1 Nov 2022 (T+270)
4 of 4 declarations
About Poradosu Enrique
Poradosu Enrique is the Chief Science & Business Officer at Nuvectis Pharma, Inc. In this role, he oversees the company's scientific and business initiatives, contributing to its strategic development. His expertise is essential in aligning scientific objectives with business opportunities.
